Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Marion Hippius"'
Autor:
Bernd Drewelow, Jacek Szymanski, I. R. Guenther, Marietta Rottenkolber, Farker K, Werner Siegmund, Jörg Hasford, Marion Hippius, Sven Schmiedl, P. A. Thuermann
Publikováno v:
Expert opinion on drug safety. 17(2)
Background: Studies evaluating the impact of age and potentially inappropriate medication (PIM) on avoidable adverse drug reactions (ADRs) are scarce. Methods: In this prospective, multi-center, long-term (8.5 years) observational study, we analysed
Autor:
Christian T. Dietzel, Marion Hippius, Sandra Abert, Andreas Stallmach, Hendryk Richert, Ute Merkel
Publikováno v:
Journal of Controlled Release. 161:722-727
Human absorption studies are used to test new drug candidates for their bioavailability in different regions of the gastrointestinal tract. In order to replace invasive techniques (e.g. oral or rectal intubation) a variety of externally controlled ca
Autor:
Farker K, Dominik Rottenkolber, Joerg Hasford, Marion Hippius, Marietta Rottenkolber, P. A. Thuermann, Sven Schmiedl, Silke C. Mueller, Karen Saljé
Publikováno v:
Pharmacoepidemiology and Drug Safety. 20:626-634
Purpose German hospital reimbursement modalities changed as a result of the introduction of Diagnosis Related Groups (DRG) in 2004. Therefore, no data on the direct costs of adverse drug reactions (ADRs) resulting in admissions to departments of inte
Autor:
Marion Hippius
Publikováno v:
Therapeutische Umschau. 68:47-53
Unerwünschte Arzneimittelwirkungen (UAW) und Interaktionen führen nicht nur zu Krankenhausaufnahmen, sondern verlängern auch den Aufenthalt der Patienten. Die daraus entstehenden Kosten belasten das Gesundheitssystem zusätzlich. Die meisten UAW s
Autor:
Jörg Hasford, Jacek Szymanski, Grit Haase, I. R. Guenther, P. A. Thuermann, Marietta Rottenkolber, K. May, Silke C. Mueller, Marion Hippius
Publikováno v:
Drug Safety. 31:885-960
Autor:
K. May, Sara Haack, Marion Hippius, Grit Haase, Petra A. Thürmann, Sven Schmiedl, Bernd Drewelow, Jörg Hasford, Ilselore R. Reimann, Jacek Szymanski, Marietta Rottenkolber, Werner Siegmund
Publikováno v:
Medizinische Klinik. 102:603-611
D Background: Although the value of digitalis glycosides in the treatment of heart failure is limited, approximately 255 million DDDs of digitalis glycosides (DGs) were prescribed in Germany in 2004. D Methods: The authors analyzed data from adverse
Autor:
Marion Hippius, Joerg Fuchs
Publikováno v:
Patient Education and Counseling. 67:157-168
Objective Regardless of all efforts by the supervisory authority and the manufacturers to ensure that package inserts are patient-oriented, they are still under discussion. The survey package insert test (PAINT) aimed to examine the availability and
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 44:31-37
Objective: Several clinical trials have demonstrated that oxaliplatin is a useful agent in combination with 5-fluorouracil (5-FU) and folinic acid (FA) for the treatment of patients with colorectal carcinoma. The aims of this pilot study were to eval
Autor:
K. May, Jörg Hasford, Werner Siegmund, Ilselore R. Reimann, S. Haack, U. Werner, Jacek Szymanski, Bernd Drewelow, P. A. Thuermann, Marion Hippius, Grit Haase
Publikováno v:
Drug Safety. 29:911-1010
Autor:
Jörg Hasford, Jacek Szymanski, Werner Siegmund, Ilselore R. Reimann, Grit Haase, K. May, P. A. Thuermann, Marietta Rottenkolber, Sven Schmiedl, Marion Hippius, Bernd Drewelow
Publikováno v:
Drug Safety. 29:911-1010